STAT3 and mesenchymal cell neoplasm: Hallmarks of the Mesenchymal subtype, including a slight global DNA hypermethylation, enrichment of the hazardous RETM918T mutation, and STAT3 signaling activation, may be causally related and collectively serve as molecular determinants of poorer prognosis in Mesenchymal tumors.